Page 77 - Badan POM Pastikan Terus Kawal Keamanan dan Mutu Vaksin COVID-19 Sebelum dan Selama Peredaran
P. 77

Judul                 : BPOM Obtains Sinovac Vaccine Test Results from Brazil,
                                       Turkey

               Nama Media            : tempo.co

               Tanggal               : 9 Januari 2021
               Halaman/URL           : https://en.tempo.co/read/1421274/bpom-obtains-sinovac-
                                     vaccine-test-results-from-brazil-turkey

               Tipe Media            : Media Online



                                                          Head  of  the  Covid-19  mitigation  and
                                                          national  economic  recovery  committee
                                                          (PC-PEN  Committee)  Airlangga  Hartarto
                                                          assures  that  the  Food  and  Drugs
                                                          Monitoring  Agency  (BPOM)  has  obtained
                                                          the  test  reports  of  the  Sinovac  vaccine
                                                          conducted in Brazil and Turkey.

                                                          “The  emergency  use  authorization  has
               been issued in Turkey and we have already received the study report from Brazil,”
               said Airlangga on Friday, January 8. The minister claims that the BPOM will soon
               issue its own EUA.

               The BPOM will reportedly announce the authorization in a media briefing today.

               Turkey previously reported that the vaccine efficacy rate was 91.25 percent for the
               CoronaVac after their third trial was completed. They claimed that it can potentially
               improve following an evaluation from the Turkish scientific committee.

               Meanwhile, Brazil  released  a  report  on  the  experimental  vaccine  developed
               by Sinovac Biotech that recorded 78 percent efficacy against Covid-19.
   72   73   74   75   76   77   78   79   80   81   82